Linagliptin as add-on to empagliflozin and metformin in patients with type 2 diabetes: Two 24-week randomized, double-blind, double-dummy, parallel-group trials

DSpace Repository

Linagliptin as add-on to empagliflozin and metformin in patients with type 2 diabetes: Two 24-week randomized, double-blind, double-dummy, parallel-group trials

Author: Tinahones, Francisco J.; Gallwitz, Baptist; Nordaby, Matias; Goetz, Sophia; Maldonado-Lutomirsky, Mario; Woerle, Hans J.; Broedl, Uli C.
Tübinger Autor(en):
Gallwitz, Baptist
Published in: Diabetes Obesity & Metabolism (2017), Bd. 19, H. 2, S. 266-274
Verlagsangabe: Wiley - Blackwell
Language: English
Full text: http://dx.doi.org/10.1111/dom.12814
ISSN: 1463-1326
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)